Althea Group Holdings Ltd

AU:AGH Australia Drug Manufacturers - Specialty & Generic
Market Cap
$10.55 Million
AU$17.03 Million AUD
Market Cap Rank
#30601 Global
#892 in Australia
Share Price
AU$0.02
Change (1 day)
-2.86%
52-Week Range
AU$0.02 - AU$0.03
All Time High
AU$1.23
About

Peak Processing Limited, together with its subsidiaries, manufactures, distributes, and sells recreational cannabis products in Canada and the United States. The company offers cannabis products, including beverages, hydrocarbon extracts, oils, vapes, oils, topicals, powders, infused flowers, and edibles. It also provides market insights and analysis, product development, manufacturing, commercia… Read more

Althea Group Holdings Ltd (AGH) - Net Assets

Latest net assets as of June 2025: AU$-574.00K AUD

Based on the latest financial reports, Althea Group Holdings Ltd (AGH) has net assets worth AU$-574.00K AUD as of June 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$20.49 Million) and total liabilities (AU$21.06 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets AU$-574.00K
% of Total Assets -2.8%
Annual Growth Rate N/A
5-Year Change -101.34%
10-Year Change N/A
Growth Volatility 210.86

Althea Group Holdings Ltd - Net Assets Trend (2018–2025)

This chart illustrates how Althea Group Holdings Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Althea Group Holdings Ltd (2018–2025)

The table below shows the annual net assets of Althea Group Holdings Ltd from 2018 to 2025.

Year Net Assets Change
2025-06-30 AU$-574.00K -282.80%
2024-06-30 AU$314.00K -98.95%
2023-06-30 AU$29.77 Million -28.18%
2022-06-30 AU$41.45 Million -2.92%
2021-06-30 AU$42.70 Million -7.43%
2020-06-30 AU$46.12 Million +170.48%
2019-06-30 AU$17.05 Million +443.76%
2018-06-30 AU$3.14 Million --

Equity Component Analysis

This analysis shows how different components contribute to Althea Group Holdings Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 9242741500.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (June 2025)

Component Amount Percentage
Common Stock AU$93.97 Million %
Other Comprehensive Income AU$-244.00K %
Total Equity AU$-574.00K 100.00%

Althea Group Holdings Ltd Competitors by Market Cap

The table below lists competitors of Althea Group Holdings Ltd ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Althea Group Holdings Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 314,000 to -574,000, a change of -888,000 (-282.8%).
  • Net loss of 8,346,999 reduced equity.
  • Share repurchases of 3,833,000 reduced equity.
  • Other comprehensive income decreased equity by 2,969,999.
  • Other factors increased equity by 14,261,998.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income AU$-8.35 Million -1454.18%
Share Repurchases AU$3.83 Million -667.77%
Other Comprehensive Income AU$-2.97 Million -517.42%
Other Changes AU$14.26 Million +2484.67%
Total Change AU$- -282.80%

Book Value vs Market Value Analysis

This analysis compares Althea Group Holdings Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2018-06-30 AU$0.02 AU$0.02 x
2019-06-30 AU$0.10 AU$0.02 x
2020-06-30 AU$0.20 AU$0.02 x
2021-06-30 AU$0.17 AU$0.02 x
2022-06-30 AU$0.14 AU$0.02 x
2023-06-30 AU$0.08 AU$0.02 x
2024-06-30 AU$0.00 AU$0.02 x
2025-06-30 AU$0.00 AU$0.02 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Althea Group Holdings Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 0.00%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -53.87%
  • • Asset Turnover: 0.76x
  • • Equity Multiplier: 0.00x
  • Recent ROE (0.00%) is above the historical average (-1307.80%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2018 -59.70% -17462.69% 0.00x 1.05x AU$-2.19 Million
2019 -50.87% -1131.03% 0.04x 1.07x AU$-10.38 Million
2020 -32.02% -297.08% 0.09x 1.14x AU$-19.38 Million
2021 -35.24% -135.88% 0.21x 1.26x AU$-19.32 Million
2022 -29.25% -60.39% 0.35x 1.36x AU$-16.27 Million
2023 -46.11% -55.29% 0.51x 1.62x AU$-16.70 Million
2024 -10209.24% -109.03% 1.24x 75.32x AU$-32.09 Million
2025 0.00% -53.87% 0.76x 0.00x AU$-8.29 Million

Industry Comparison

This section compares Althea Group Holdings Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $16,650,401
  • Average return on equity (ROE) among peers: -162.22%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Althea Group Holdings Ltd (AGH) AU$-574.00K -59.70% N/A $6.03 Million
Aft Pharmaceuticals Ltd (AFP) $28.23 Million -47.00% 1.31x $53.97 Million
BOD Science Ltd (BOD) $3.47 Million -155.95% 0.53x $1.38 Million
BPH Global Ltd (BP8) $-1.46 Million 0.00% 0.00x $781.31K
Cann Group Ltd (CAN) $-2.77 Million 0.00% 0.00x $2.39 Million
ECS Botanics Holdings Ltd (ECS) $188.48K -116.04% 0.13x $2.73 Million
IDT Australia Ltd (IDT) $25.01 Million -24.32% 0.25x $8.48 Million
Invion Ltd (IVX) $19.58 Million -11.45% 0.02x $2.48 Million
Little Green Pharma Ltd (LGP) $77.26 Million -10.55% 0.12x $14.26 Million
Live Verdure Ltd (LV1) $362.12K -1094.69% 2.55x $28.27 Million